Long-Term Drug Shortage – Cystaran® (cysteamine)

The drug shortage of Leadiant’s Cystaran (cysteamine) 0.44% ophthalmic solution is ongoing. Cystaran has been unavailable due to an independent manufacturer declaring bankruptcy. April 9, 2021

Long-Term Drug Shortage – nefazodone

The drug shortage of Teva’s nefazodone tablets is ongoing. Nefazodone has been unavailable for at least 90 days due to raw ingredient supply issues. April 7, 2021

Trodelvy® (sacituzumab govitecan-hziy) – Expanded indication

Gilead announced the FDA approval of Trodelvy (sacituzumab govitecan-hziy), for the treatment of adult patients with unresectable locally advanced or metastatic triple negative breast cancer (mTNBC) who have received two or more prior systemic therapies, at least one of them for metastatic disease. April 7, 2021